In contrast, Hagemann–Jensen et al. [63] showed that MSA alters the expression of NKG2D ligands on tumor cells, thereby influencing better recognition and elimination by NKG2D-expressing immune effector cells. This evidence concerns the gene KLRK1 and neoplasm.